OTCMKTS:CNVVY - Convatec Group Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 7
  • Breakdown:
  • 2 Sell Ratings
  • 3 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$10.57
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New Convatec Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CNVVY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CNVVY

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 7 analysts offering 12 month price targets for Convatec Group in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $10.57.
Hold
The current consensus among 7 investment analysts is to hold stock in Convatec Group. This rating has held steady since April 2020, when it changed from a Sell consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 1 sell ratings
6/3/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 1 sell ratings
9/1/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
11/30/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 2 sell ratings
2/28/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 2 sell ratings
5/28/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 3 sell ratings
8/26/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 3 sell ratings
10/25/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 2 sell ratings
11/24/2020

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 2 sell ratings

DateBrokerageActionRatingPrice TargetDetails
11/18/2020Morgan StanleyReiterated RatingEqual Weight
i
10/29/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
i
10/29/2020BarclaysReiterated RatingOverweight
i
9/29/2020Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform
i
9/23/2020BarclaysUpgradeEqual Weight ➝ Overweight
i
9/23/2020Jefferies Financial GroupDowngradeBuy ➝ Hold
i
8/7/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
i
8/7/2020Credit Suisse GroupReiterated RatingUnderperform
i
7/2/2020Morgan StanleyReiterated RatingEqual Weight
i
7/1/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
i
6/26/2020Peel HuntDowngradeBuy
i
5/18/2020BarclaysReiterated RatingEqual Weight
i
4/1/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
i
1/20/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight
i
12/9/2019Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform
i
11/12/2019Sanford C. BernsteinInitiated CoverageUnderperform
i
10/26/2018UBS GroupDowngradeBuy ➝ Neutral
i
10/16/2018JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
i
10/16/2018The Goldman Sachs GroupDowngradeBuy ➝ Neutral
i
10/3/2018Jefferies Financial GroupInitiated CoverageBuy
i
(Data available from 11/25/2015 forward)
Convatec Group logo
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and urological disorders, as well as devices and products use in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to the manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospitals and the home healthcare sector. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group Plc was incorporated in 2016 and is headquartered in Reading, the United Kingdom.
Read More

Today's Range

Now: $10.57
$10.57
$10.57

50 Day Range

MA: $9.78
$9.10
$10.74

52 Week Range

Now: $10.57
$6.69
$11.28

Volume

N/A

Average Volume

2,253 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A